BIOPEOPLE
OneSource Specialty Pharma appoints three new independent directors
OneSource Specialty Pharma Limited has announced the appointment of three new non-executive independent directors to its Board— Dr Claudio Albrecht, Debarati Sen and Vijay Karwal— effective February 27, 2025. The directors bring decades of leadership experience and expertise in Pharma, Business Strategy, Transformation, Merger & Acquisition( M & A) among others.
With the appointment of these nonexecutive directors, the OneSource Board now comprises Chairperson, Arun Kumar – Founder & Non- Executive Director and independent non-executive directors, Dr Claudio Albrecht, Debarati Sen, Dr Rashmi H Barbhaiya, and Vijay Karwal. Also appointed to the board are Bharat D Shah – Non-Executive, Non- Independent Director; and Neeraj Sharma – CEO & Managing Director.
Commenting on the development Neeraj Sharma CEO OneSource said“ I am delighted to welcome Debarati Sen, Dr Claudio Albrecht, and Vijay Karwal, to our Board. Their expertise, strategic leadership, and global market insights will support us as we embark on the next chapter of our growth journey. Each of them will bring a new perspective that aligns perfectly with our aspiration to position OneSource as a global leader in the CDMO sector. I am confident that their contributions will not only help us achieve greater.”
Eris Lifesciences appoints Murari Ranganathan to spearhead cardiometabolic business
Eris Lifesciences Limited, a leading Indian branded formulations manufacturing company has appointed Murari Ranganathan as President, Cardiometabolic Business. He will be based out of the company’ s Mumbai office and take charge of the company’ s Anti-Diabetes and Cardiology businesses.
Prior to joining Eris, Ranganathan was Commercial Director, Women’ s Health, Metabolics, and International Business at Abbott India Limited. He joined Abbott in 2010 as Head Sales, Medical Nutrition and played a variety of roles in his 15-year stint with the
50
BioVoiceNews | April 2025